vs
Side-by-side financial comparison of GREENE COUNTY BANCORP INC (GCBC) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
GREENE COUNTY BANCORP INC is the larger business by last-quarter revenue ($22.2M vs $20.4M, roughly 1.1× Sight Sciences, Inc.). GREENE COUNTY BANCORP INC runs the higher net margin — 46.3% vs -20.4%, a 66.7% gap on every dollar of revenue. On growth, GREENE COUNTY BANCORP INC posted the faster year-over-year revenue change (23.8% vs 6.9%). GREENE COUNTY BANCORP INC produced more free cash flow last quarter ($6.2M vs $-2.0M). Over the past eight quarters, GREENE COUNTY BANCORP INC's revenue compounded faster (18.9% CAGR vs 2.9%).
Bank of Greene County is an American federally-chartered savings bank headquartered in Catskill, NY. The bank's branches are located in the Upstate New York counties of Greene, Columbia, Albany, Ulster, and Rensselaer.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
GCBC vs SGHT — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.2M | $20.4M |
| Net Profit | $10.3M | $-4.2M |
| Gross Margin | — | 87.3% |
| Operating Margin | 52.0% | -18.0% |
| Net Margin | 46.3% | -20.4% |
| Revenue YoY | 23.8% | 6.9% |
| Net Profit YoY | 37.4% | 64.9% |
| EPS (diluted) | $0.60 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.2M | $20.4M | ||
| Q3 25 | $21.5M | $19.9M | ||
| Q2 25 | $20.5M | $19.6M | ||
| Q1 25 | $20.1M | $17.5M | ||
| Q4 24 | $17.9M | $19.1M | ||
| Q3 24 | $16.9M | $20.2M | ||
| Q2 24 | $16.6M | $21.4M | ||
| Q1 24 | $15.7M | $19.3M |
| Q4 25 | $10.3M | $-4.2M | ||
| Q3 25 | $8.9M | $-8.2M | ||
| Q2 25 | $9.3M | $-11.9M | ||
| Q1 25 | $8.1M | $-14.2M | ||
| Q4 24 | $7.5M | $-11.8M | ||
| Q3 24 | $6.3M | $-11.1M | ||
| Q2 24 | $6.7M | $-12.3M | ||
| Q1 24 | $5.9M | $-16.3M |
| Q4 25 | — | 87.3% | ||
| Q3 25 | — | 86.4% | ||
| Q2 25 | — | 84.8% | ||
| Q1 25 | — | 86.2% | ||
| Q4 24 | — | 86.8% | ||
| Q3 24 | — | 83.9% | ||
| Q2 24 | — | 85.8% | ||
| Q1 24 | — | 85.5% |
| Q4 25 | 52.0% | -18.0% | ||
| Q3 25 | 47.4% | -39.7% | ||
| Q2 25 | 53.5% | -59.6% | ||
| Q1 25 | 44.6% | -79.2% | ||
| Q4 24 | 45.0% | -62.5% | ||
| Q3 24 | 39.6% | -55.7% | ||
| Q2 24 | 41.2% | -59.2% | ||
| Q1 24 | 39.4% | -76.4% |
| Q4 25 | 46.3% | -20.4% | ||
| Q3 25 | 41.2% | -41.0% | ||
| Q2 25 | 45.6% | -61.0% | ||
| Q1 25 | 40.1% | -80.8% | ||
| Q4 24 | 41.7% | -62.1% | ||
| Q3 24 | 37.1% | -54.9% | ||
| Q2 24 | 40.6% | -57.7% | ||
| Q1 24 | 37.3% | -84.4% |
| Q4 25 | $0.60 | $-0.07 | ||
| Q3 25 | $0.52 | $-0.16 | ||
| Q2 25 | $0.55 | $-0.23 | ||
| Q1 25 | $0.47 | $-0.28 | ||
| Q4 24 | $0.44 | $-0.23 | ||
| Q3 24 | $0.37 | $-0.22 | ||
| Q2 24 | $0.39 | $-0.25 | ||
| Q1 24 | $0.34 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $92.0M |
| Total DebtLower is stronger | — | $42.4M |
| Stockholders' EquityBook value | $258.3M | $63.9M |
| Total Assets | $3.1B | $115.3M |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $92.0M | ||
| Q3 25 | — | $92.4M | ||
| Q2 25 | — | $101.5M | ||
| Q1 25 | $155.5M | $108.8M | ||
| Q4 24 | $166.4M | $120.4M | ||
| Q3 24 | — | $118.6M | ||
| Q2 24 | $190.4M | $118.2M | ||
| Q1 24 | — | $127.3M |
| Q4 25 | — | $42.4M | ||
| Q3 25 | — | $42.4M | ||
| Q2 25 | — | $42.4M | ||
| Q1 25 | — | $42.4M | ||
| Q4 24 | — | $40.0M | ||
| Q3 24 | — | $37.1M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $35.0M |
| Q4 25 | $258.3M | $63.9M | ||
| Q3 25 | $248.2M | $64.3M | ||
| Q2 25 | $238.8M | $70.0M | ||
| Q1 25 | $229.0M | $77.6M | ||
| Q4 24 | $218.4M | $87.5M | ||
| Q3 24 | $216.3M | $95.0M | ||
| Q2 24 | $206.0M | $101.6M | ||
| Q1 24 | $199.2M | $109.2M |
| Q4 25 | $3.1B | $115.3M | ||
| Q3 25 | $3.1B | $116.3M | ||
| Q2 25 | $3.0B | $122.0M | ||
| Q1 25 | $3.0B | $129.7M | ||
| Q4 24 | $3.0B | $142.8M | ||
| Q3 24 | $2.9B | $143.6M | ||
| Q2 24 | $2.8B | $149.7M | ||
| Q1 24 | $2.9B | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.4M | $-1.8M |
| Free Cash FlowOCF − Capex | $6.2M | $-2.0M |
| FCF MarginFCF / Revenue | 28.0% | -9.7% |
| Capex IntensityCapex / Revenue | 0.9% | 0.8% |
| Cash ConversionOCF / Net Profit | 0.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $47.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | $-1.8M | ||
| Q3 25 | $7.0M | $-8.7M | ||
| Q2 25 | $28.0M | $-7.5M | ||
| Q1 25 | $7.3M | $-11.6M | ||
| Q4 24 | $5.3M | $-3.5M | ||
| Q3 24 | $2.1M | $362.0K | ||
| Q2 24 | $24.9M | $-9.5M | ||
| Q1 24 | $5.6M | $-9.8M |
| Q4 25 | $6.2M | $-2.0M | ||
| Q3 25 | $6.5M | $-8.9M | ||
| Q2 25 | $27.3M | $-7.8M | ||
| Q1 25 | $7.3M | — | ||
| Q4 24 | $5.1M | $-3.6M | ||
| Q3 24 | $2.0M | $311.0K | ||
| Q2 24 | $23.4M | $-9.5M | ||
| Q1 24 | $4.9M | $-9.9M |
| Q4 25 | 28.0% | -9.7% | ||
| Q3 25 | 30.4% | -44.7% | ||
| Q2 25 | 133.3% | -39.6% | ||
| Q1 25 | 36.1% | — | ||
| Q4 24 | 28.6% | -18.9% | ||
| Q3 24 | 11.8% | 1.5% | ||
| Q2 24 | 141.2% | -44.7% | ||
| Q1 24 | 31.3% | -51.4% |
| Q4 25 | 0.9% | 0.8% | ||
| Q3 25 | 1.9% | 0.9% | ||
| Q2 25 | 3.4% | 1.1% | ||
| Q1 25 | 0.3% | 0.0% | ||
| Q4 24 | 1.0% | 0.7% | ||
| Q3 24 | 0.9% | 0.3% | ||
| Q2 24 | 9.1% | 0.4% | ||
| Q1 24 | 4.2% | 0.6% |
| Q4 25 | 0.62× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 3.00× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.71× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 3.70× | — | ||
| Q1 24 | 0.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GCBC
Segment breakdown not available.
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
